Context Female lower urinary tract symptoms (LUTS) are a common presentation in
urological practice. Thus far, only a limited number of female LUTS conditions have been …

Background Mirabegron is an established treatment alternative to antimuscarinic therapy for
patients with overactive bladder (OAB), as shown by efficacy and tolerability data from phase …

Introduction The prevalence of urinary incontinence and of other lower urinary tract
symptoms increases after the menopause and affects between 38% and 55% of women …

Electromyographic biofeedback (EMG-BF) can be regarded as an adjuvant to pelvic floor
muscle (PFM) training (PFMT) for the management of stress urinary incontinence (SUI). This …

Background Mirabegron, a β3-adrenoreceptor agonist, is an alternative drug to
antimuscarinics for overactive bladder (OAB) symptoms. Objective To summarise safety and …

Introduction: High performance female athletes may be a risk group for the development of
urinary incontinence due to the imbalance of forces between the abdomen and the pelvis …

Context Urinary incontinence (UI) is a common condition in elderly men causing a severe
worsening of quality of life, and a significant cost for both patients and health systems …

Background: Flat Magnetic Stimulation (FMS) is characterized by a stimulation generated by
electromagnetic fields with a homogenous profile. One possible application is the treatment …

Lower urinary tract dysfunction (LUTD) is common and causes a spectrum of morbidity and
decreased quality of life (QoL) for patients. LUTD can range from urinary retention to urge …

Urinary incontinence (UI) is a bothersome symptom with population studies suggesting a
prevalence of 13.1% in women and 5.4% in men. While a significant cohort of patients with …